Last reviewed · How we verify
LID104
LID104 is a small molecule that targets the serotonin receptor.
LID104 is a small molecule that targets the serotonin receptor. Used for Major depressive disorder.
At a glance
| Generic name | LID104 |
|---|---|
| Sponsor | EMS |
| Drug class | SSRI |
| Target | 5-HT receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It works by binding to the serotonin receptor, which leads to a decrease in serotonin levels in the brain. This decrease in serotonin levels is thought to be beneficial for patients with depression.
Approved indications
- Major depressive disorder
Common side effects
- Nausea
- Headache
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |